CYP 9.30% 23.5¢ cynata therapeutics limited

Ann: Cynata Successfully Completes Capital Raising, page-37

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 35,472 Posts.
    lightbulb Created with Sketch. 2863
    Chris, long term, my opinion is CYP deal will be far superior, NO costs (less dilution)...and far more scalable.

    Once GvHD shows safety, then it's really on in the multiples of Fuji GvHD deal.

    The other targets are 10-20x GvHD value

    PS: already acknowledged RSG "looks" better ST, and IS a deal...But 12 months + CYP far more potential imo.
    Last edited by Sector: 23/01/17
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.